Abstract Body

Worldwide, 71 million persons are HCV infected but only a small proportion have been diagnosed and treated. Increasing access to care in low and middle income countries (LMICs) will require adoption of simplified service delivery models such as decentralization and task shifting to non-specialists. The evidence base for their effectiveness in HCV care remains limited. We conducted a systematic review and meta-analysis to establish the effectiveness of decentralization and task-shifting on outcomes across the continuum of HCV care in different populations.

Bibliographic databases and conference abstracts were searched for English language clinical trials or observational studies published between 01/2008 to 02/2018 that evaluated these interventions. Outcomes were testing and HCV viral load uptake, linkage to care, treatment uptake, and cure (SVR12)) in PWID, prisoners, PLHIV, and general population. Decentralisation was defined as either full (FD) (testing and treatment at same primary care or harm reduction site), or partial (PD) (testing at decentralized site and referral for treatment) and task-shifting as HCV treatment by non-specialists (primary care physicians or nurses). Data were pooled using random effects meta-analysis and meta-regression was used to explore heterogeneity.

97 studies from 18 countries (11 were LMIC) were included. 82 were single arm studies and 15 had a comparator arm (RCTs, non-RCT or cohort studies). 40 (41.2%) were in PWID, 13 (13.4%) in prisoners, 42 (43.3%) in general population, and 2 in PLHIV. 34 and 35 studies respectively used DAA and IFN based regimens. Among PWID, FD (n=29) compared to PD (n=11) had higher testing uptake 88% (95%CI 78-98) vs. 47% (95%CI 4-99), and linkage to care 80% (95%CI 62-98) vs. 53% (95%CI 30-77), but similar SVR rates: FD 93% (95%CI 89-97) vs PD 88% (95% CI 84–93). Results were similar for FD (n=19) and PD (n=23) in general population studies. Task-shifting to non-specialists achieved similar SVR12 to specialist care for both PWID 92% (95%CI 88-97) vs. 92% (95%CI 85-99) and in general population 92% (95%CI 87–96) vs. 91% (95%CI 87–95).

Both decentralization and task-shifting to non-specialists achieved high levels of HCV cure across a range of populations and settings. These findings support adoption of these service delivery models to promote testing and treatment scale-up in national programmes.